Home | Business News | CBJ Newsmakers | Tetra Bio-Pharma’s Subsidiary, Panag Pharma, Obtains Health Canada Authorization to Commence Its First Veterinary Clinical Study Tetra Bio-Pharma’s Subsidiary, Panag Pharma, Obtains Health Canada Authorization to Commence Its First Veterinary Clinical Study CBJ Newsmakers RecommendedBombardier transfers first two FLEXITY trams to Karlsruhe in GermanyGlobal Care Capital Announces LOI for Acquisition of Healthview TechnologiesFireweed Zinc Closes $5.2 Million Private Placement
